Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 0.29 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 0.42 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 0.47 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 0.44 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 0.41 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 0.33 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 0.33 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 0.34 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 0.0 | BCD100322A01 | 1.33 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 0.5 | BCD100322A03 | 0.87 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 1.0 | BCD100322A07 | 1.34 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 2.0 | BCD100322A11 | 1.59 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 4.0 | BCD100322A15 | 1.72 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 8.0 | BCD100322A19 | 1.66 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 12.0 | BCD100322A23 | 1.5 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | C | 24.0 | BCD100322A27 | 1.68 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 0.34 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 0.37 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 0.24 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 0.43 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 0.22 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 0.3 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 0.24 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol | 0.5 | BCD100322A04 | 1.35 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol | 1.0 | BCD100322A08 | 2.24 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol | 2.0 | BCD100322A12 | 1.58 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol | 4.0 | BCD100322A16 | 1.63 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol | 8.0 | BCD100322A20 | 1.5 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol | 12.0 | BCD100322A24 | 2.06 | pmol/sample |
| LMFA03010022 | 13,14-dihydro-15-keto-PGD2 | 25OH-Chol | 24.0 | BCD100322A28 | 1.52 | pmol/sample |